Filter
864
Text search:
pharmaceutical
regulations
Featured
71
231
Language
Document type
395
188
146
51
51
12
10
6
3
1
1
Countries / Regions
48
32
27
26
25
23
23
20
19
19
18
17
17
14
14
14
13
12
11
11
11
9
9
9
9
8
7
6
6
6
6
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
390
45
34
27
24
15
6
Toolboxes
135
91
72
34
28
24
21
19
18
18
16
15
12
12
12
11
9
6
5
2
2
2
2
1
Antimicrobial resistance (AMR) is an increasing worldwide public health problem with
important implications for the European Union (EU). When antibiotics become
ineffective, bacterial infections lead to increased morbidity, use of healthcare,
mortality and cost. Globally, estimates suggest that
...
Value in Health Regional Issues 4 C (2014) 37-40
Towards the Peoples Health Assembly Book -5
Towards the Peoples Health Assembly Book -1
Towards a Healthier Botswana
“towards quality health and social welfare services”
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th
...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2
...
Health care waste can be difficult to treat and dispose of safely. The environmental and health impacts of waste put extra pressure on resources. Therefore, it is important to try and reduce the quantities of waste wherever possible. Ensure waste is segregated properly at the point of disposal. It i
...
HRH SA 2030 | Draft HR Strategy for the Health Sector: 2012/13 – 2016/17 Consultation Document
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
